EUVIMEDEUVIMED entdecken
Open Access

Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes

Wenran Li iD, Yingyu Cheng, Aoyuan Cui, Mengyao Huang, Qingxia Huang, Qi Wang, Mingfeng Xia, Jiange Qiu, Qianqian Peng, Jiarui Li, Huating Li, Yong Wang und 10 weitere

Diabetes · 2025

DOI: 10.2337/db25-0354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Wenran Li und 21 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy o…. Hauptthemen laut MEDLINE: Proteomics, Metabolomics, Diabetes Mellitus, Epigenesis, Genetic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes holds significant social importance due to its high incidence rate and multitude of associated complications. The identification of diabetes biomarkers and the understanding of the intricate biological mechanisms underlying diabetes are crucial for the early diagnosis and treatment of diabetes. In this study, we conducted comprehensive omics profiling of CpGs, plasma proteins, and serum metabolites in an National Survey of Physical Traits (NSPT) cohort of 3,451 individuals, among whom 293 were patients with diabetes. Global association analysis identified 175 CpGs, 29 proteins, and 93 metabolites significantly linked to diabetes, among which 43 CpGs and 25 metabolites were validated in an independent cohort comprising 532 individuals. Mendelian randomization and mediation analysis identified 20 causal biomarkers and 190 signaling pathways linking biomarkers from different layers. By integrating the cross-omics evidence, we provide a list of putative causal biomarkers of diabetes to serve as a valuable resource for the diabetes community. Cross-omics integration prioritized biomarkers for therapeutic targeting, highlighting COLEC11 as an example of a potential target and whose function was further validated in vitro. The early-prediction model using the prioritized biomarkers improved the area under the receiver operating characteristic curve by 27.5% compared with the baseline model, using clinical features alone. Our findings provide a comprehensive list of prioritized multiomics biomarkers and elucidate specific signaling pathways in diabetes, contributing significantly to the selection of therapeutic target and the understanding of diabetes pathophysiology. Article Highlights A total of 175 CpGs, 29 proteins, and 93 metabolites were identified as associated with diabetes, among which 43 CpGs and 25 metabolites were validated in an independent cohort. Causal and mediation analyses revealed 20 biomarkers and 190 signaling pathways involved in diabetes development. The integrative multiomics prioritization provides the community with an ordered list of diabetes biomarkers. We experimentally validated one of the prioritized proteins, COLEC11, and demonstrated its involvement in lipid metabolism. Our findings prioritize potential therapeutic targets and demonstrate that integrating multiomics biomarkers improves diabetes risk prediction beyond traditional clinical models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsMetabolomicsDiabetes MellitusEpigenesis, GeneticDiabetes Mellitus, Type 2HumansMaleBiomarkersFemaleMiddle AgedEpigenomicsAdultMendelian Randomization AnalysisMultiomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
  • CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Metabonomics and Systems Biology Laboratory at Shanghai International Cent…
  • Department of Endocrinology and Metabolism, Zhongshan Hospital and Fudan Institute for Metabolic Diseases, Fudan University, Shanghai, China.
  • Academy of Medical Science, Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

ORCID-Profile: Wenran Li, Huiru Tang, Bing-Hua Jiang, Li Jin, Yu Li, Sijia Wang

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Science and Technology Major Project
  • Key R&D Program of China
  • Excellent Academic Leaders Program
  • Strategic Priority Research Program of Chinese Academy of Sciences
  • Program for Stable Support of Basic Research
  • Chinese Academy of Sciences Young Team
  • NSFC

Zitieren

APA

Li, W., Cheng, Y., Cui, A., Huang, M., Huang, Q., Wang, Q., Xia, M., Qiu, J., Peng, Q., Li, J., Li, H., Wang, Y., Zong, G., Zheng, Y., Wang, J., Gao, X., Ding, C., Tang, H., Jiang, B. H., …, & Wang, S. (2025). Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes. Diabetes. https://doi.org/10.2337/db25-0354

Vancouver

Li W, Cheng Y, Cui A, Huang M, Huang Q, Wang Q, et al. Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes. Diabetes. 2025. doi:10.2337/db25-0354

BibTeX
@article{Li2025,
  author = {Li, Wenran and Cheng, Yingyu and Cui, Aoyuan and Huang, Mengyao and Huang, Qingxia and Wang, Qi and Xia, Mingfeng and Qiu, Jiange and Peng, Qianqian and Li, Jiarui and Li, Huating and Wang, Yong and Zong, Geng and Zheng, Yan and Wang, Jiucun and Gao, Xin and Ding, Chen and Tang, Huiru and Jiang, Bing-Hua and Jin, Li and Li, Yu and Wang, Sijia},
  title = {Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db25-0354}
}
Kostenlos starten →